Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Statins in the treatment of acute ischemic stroke.

Montecucco F, Quercioli A, Mirabelli-Badenier M, Viviani GL, Mach F.

Curr Pharm Biotechnol. 2012 Jan;13(1):68-76. Review.

PMID:
21470160
2.

Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors.

Gil-Núñez AC, Villanueva JA.

Cerebrovasc Dis. 2001;11 Suppl 1:85-95. Review.

PMID:
11244205
3.

Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?

Vaughan CJ, Delanty N, Basson CT.

CNS Drugs. 2001;15(8):589-96.

PMID:
11524031
4.

Statins and neuroprotection.

Delanty N, Vaughan CJ, Sheehy N.

Expert Opin Investig Drugs. 2001 Oct;10(10):1847-53. Review.

PMID:
11772290
5.

Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.

Miida T, Hirayama S, Nakamura Y.

J Atheroscler Thromb. 2004;11(5):253-64. Review.

6.

Treatment with statins in the acute phase of ischemic stroke.

Montaner J.

Expert Rev Neurother. 2005 Mar;5(2):211-21. Review.

PMID:
15853491
7.

HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.

Moonis M, Fisher M.

Expert Rev Neurother. 2004 Mar;4(2):241-7. Review.

PMID:
15853565
8.

Prevention of stroke and dementia with statins: Effects beyond lipid lowering.

Vaughan CJ.

Am J Cardiol. 2003 Feb 20;91(4A):23B-29B. Review.

PMID:
12615295
9.

The evolving role of statins in the management of atherosclerosis.

Vaughan CJ, Gotto AM Jr, Basson CT.

J Am Coll Cardiol. 2000 Jan;35(1):1-10. Review.

10.

How do HMG-CoA reductase inhibitors prevent stroke?

Bedi A, Flaker GC.

Am J Cardiovasc Drugs. 2002;2(1):7-14. Review.

PMID:
14727994
11.
12.

Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.

Elkind MS, Flint AC, Sciacca RR, Sacco RL.

Neurology. 2005 Jul 26;65(2):253-8.

PMID:
16043795
13.

Statins in stroke: prevention, protection and recovery.

Switzer JA, Hess DC.

Expert Rev Neurother. 2006 Feb;6(2):195-202. Review.

PMID:
16466299
14.

Statins: multiple mechanisms of action in the ischemic brain.

Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L.

Neuroscientist. 2007 Jun;13(3):208-13. Review.

PMID:
17519364
15.

Benefits of statins in cerebrovascular disease.

Di Napoli M.

Curr Opin Investig Drugs. 2004 Mar;5(3):295-305. Review.

PMID:
15083596
16.

Statins and stroke: prevention and beyond.

Prinz V, Endres M.

Curr Opin Neurol. 2011 Feb;24(1):75-80. doi: 10.1097/WCO.0b013e3283424c53. Review.

PMID:
21150596
17.

The acute (cerebro)vascular effects of statins.

Prinz V, Endres M.

Anesth Analg. 2009 Aug;109(2):572-84. doi: 10.1213/ane.0b013e3181a85d0e. Review.

PMID:
19608834
18.

HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.

Hess DC, Demchuk AM, Brass LM, Yatsu FM.

Neurology. 2000 Feb 22;54(4):790-6. Review.

PMID:
10690964
19.

Statins and ischemic stroke severity: cytoprotection.

Goldstein LB.

Curr Atheroscler Rep. 2009 Jul;11(4):296-300. Review.

PMID:
19500493
20.

New insights into the pleiotropic effects of statins for stroke prevention.

Pezzini A, Del Zotto E, Volonghi I, Giossi A, Costa P, Padovani A.

Mini Rev Med Chem. 2009 Jun;9(7):794-804. Review.

PMID:
19519504

Supplemental Content

Support Center